You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AT1-receptor

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ANCA Associated Vasculitis, Cardiovascular Diseases, Kidney Diseases Trial in Edinburgh (Sparsentan)

Recruiting
  • ANCA Associated Vasculitis
  • +2 more
  • Edinburgh, United Kingdom
    Centre for Cardiovascular Science, Queen's Medical Research Inst
Jan 26, 2023

Muscarinic Receptor Occupancy Trial in New Haven (Scopolamine, [11C]EMO ([11C]LSN3172176))

Not yet recruiting
  • Muscarinic Receptor Occupancy
  • New Haven, Connecticut
    Yale University
Aug 31, 2023

Cardiorenal Syndrome (CRS) Trial in Rochester (Candesartan, Placebo)

Completed
Has Results
  • Cardiorenal Syndrome (CRS)
  • Rochester, Minnesota
    Mayo Clinic
Oct 20, 2021

Preoperative Prandial State of Patients Taking Glucagon-Like

Recruiting
  • Pulmonary Aspiration
  • Gastric ultrasound
  • Houston, Texas
    The University of Texas Health Science Center at Houston
Jun 6, 2023

Placenta Accreta Trial in Assiut (Pregnant women at 28-32 weeks, at delivery)

Completed
  • Placenta Accreta
  • Pregnant women at 28-32 weeks
  • at delivery
  • Assiut, Egypt
    Woman's Health Hospital
Aug 19, 2022

Fanconi Anemia, Severe Aplastic Anemia, MDS Trial in Minneapolis (Total Body Irradiation (TBI) (Plan 1), Cyclophosphamide (CY)

Recruiting
  • Fanconi Anemia
  • +2 more
  • Total Body Irradiation (TBI) (Plan 1)
  • +8 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Nov 2, 2022

Based on Data From German Sick Funds That Looks at Costs of

Completed
  • Diabetes Mellitus, Type 2
  • Ingelheim am Rhein, Germany
    Boehringer Ingelheim
Jan 18, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in Chapel Hill (Nivolumab, Pembrolizumab)

Recruiting
  • Relapsed Hodgkin Lymphoma
  • Refractory Hodgkin Lymphoma
  • Nivolumab
  • Pembrolizumab
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Jul 22, 2022

Type2Diabetes, ASCVD Trial (SGLT2 inhibitor, GLP-1 receptor agonist, Combination drug)

Recruiting
  • Type2Diabetes
  • ASCVD
  • SGLT2 inhibitor
  • +2 more
  • New York, New York
  • +1 more
Dec 19, 2022

Lymphoma, B-Cell Trial in Langfang (CD19 and CD22 targeted CAR-T cells)

Not yet recruiting
  • Lymphoma, B-Cell
  • CD19 and CD22 targeted CAR-T cells
  • Langfang, Hebei, China
    Hebei Yanda Ludaopei Hospital
Dec 6, 2022

Cancer Trial in United States (JTX-4014)

Active, not recruiting
  • Cancer
  • Denver, Colorado
  • +3 more
Sep 9, 2022

ST Elevation Myocardial Infarction Trial in Geneva (Successful primary PCI, defined as primary PCI of the culprit lesion with =1

Not yet recruiting
  • ST Elevation Myocardial Infarction
  • Successful primary PCI, defined as primary PCI of the culprit lesion with ≥1 Abluminus NP polymer-free sirolimus-based nanocarrier eluting stent (Concept Medical Inc., India) implantation
  • Geneva, Switzerland
    Geneva University Hospitals
Mar 25, 2023

Gastric Cancer, Breast Cancer, Cervical Cancer Trial in New Brunswick (KK-LC-1 TCR-T cells, Aldesleukin 720,000 IU/kg IV every

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • KK-LC-1 TCR-T cells
  • Aldesleukin 720,000 IU/kg IV every eight hours
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jul 30, 2022

Ovarian Cancer Trial in United States (TPIV200, Durvalumab)

Completed
Has Results
  • Ovarian Cancer
  • TPIV200
  • Durvalumab
  • Basking Ridge, New Jersey
  • +4 more
Nov 1, 2021

Breast Tumors Trial in Israel, Korea, Republic of, United States (Atezolizumab (MPDL3280A), an engineered anti-programmed

Active, not recruiting
  • Breast Neoplasms
  • Atezolizumab (MPDL3280A), an engineered anti-programmed death-ligand 1 (PD-L1) antibody
  • +7 more
  • Birmingham, Alabama
  • +26 more
Dec 21, 2022

Carcinoma, Ductal, Breast, Breast Cancer Female, Breast Tumor Trial in Worldwide (G1T48, Palbociclib)

Completed
  • Carcinoma, Ductal, Breast
  • +6 more
  • Beverly Hills, California
  • +14 more
Dec 14, 2022

Heart Failure NYHA Class II, Heart Failure NYHA Class III, Heart Failure NYHA Class IV Trial in Phoenix, Tucson (Angiotensin

Not yet recruiting
  • Heart Failure NYHA Class II
  • +2 more
  • Angiotensin 1-7
  • Saline solution
  • Phoenix, Arizona
  • +1 more
Apr 12, 2022

Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL) Trial in Canada, United States (CC-97540)

Active, not recruiting
  • Lymphoma Non-Hodgkin
  • +2 more
  • CC-97540
  • Birmingham, Alabama
  • +13 more
Oct 28, 2022

Leukemia, Myeloid, Acute Trial in United States (VCAR33)

Not yet recruiting
  • Leukemia, Myeloid, Acute
  • VCAR33
  • La Jolla, California
  • +9 more
Aug 14, 2023

Breast Cancer Trial in United States (T-DM1)

Active, not recruiting
  • Breast Cancer
  • Duarte, California
  • +13 more
Aug 25, 2022

Non-Hodgkin Lymphoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma Trial in United States (NKTR-255 at 1.5 µg/kg, NKTR-255

Recruiting
  • Non-Hodgkin Lymphoma
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma
  • NKTR-255 at 1.5 µg/kg
  • +3 more
  • La Jolla, California
  • +26 more
Jan 10, 2023

B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

Not yet recruiting
  • B-cell Non Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Cyclophosphamide injection
  • +2 more
  • Charleston, South Carolina
    Hollings Cancer Center at Medical University of South Carolina
Jan 18, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Dedifferentiated Liposarcoma, Soft Tissue Sarcoma, Sarcoma,Soft Tissue Trial in United States (Etrumadenant, Zimberelimab)

Recruiting
  • Dedifferentiated Liposarcoma
  • +6 more
  • Basking Ridge, New Jersey
  • +6 more
May 23, 2023